{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "city": "San Francisco",
      "advisory_committee_description": "Gastroenterology, Urology",
      "address_1": "One Market, Spear Tower 36th Floor",
      "address_2": "",
      "statement_or_summary": "Summary",
      "product_code": "QMY",
      "openfda": {
        "device_name": "Computerized Behavioral Therapy Device For Treating Symptoms",
        "medical_specialty_description": "Gastroenterology, Urology",
        "regulation_number": "876.5960",
        "device_class": "2"
      },
      "zip_code": "94105",
      "applicant": "Mahana Therapeutics, Inc.",
      "decision_date": "2021-06-02",
      "decision_code": "SESE",
      "country_code": "US",
      "device_name": "Mahana Parallel Digital Cognitive Behavioral Therapy (CBT) Mobile Application for Irritable Bowel Syndrome (IBS)",
      "advisory_committee": "GU",
      "contact": "Jean-Noel  Courvoisier",
      "expedited_review_flag": "",
      "k_number": "K211372",
      "state": "CA",
      "date_received": "2021-05-04",
      "review_advisory_committee": "GU",
      "postal_code": "94105",
      "decision_description": "Substantially Equivalent",
      "clearance_type": "Special"
    }
  ]
}